At Prana Xenotransplants, we’re working at the intersection of biotechnology and compassion

Our mission is simple but ambitious

To solve the organ shortage crisis by making safe, reliable xenotransplantation a reality

Each year, countless patients in India and around the world wait for organs that never arrive. Families live in limbo, doctors are forced to make impossible decisions, and promising lives are cut short. We believe this doesn’t have to be the case.

That belief led us to a bold solution, one that rethinks where lifesaving organs can come from. Using Somatic Cell Nuclear Transfer (SCNT), we clone genetically modified porcines designed specifically for human compatibility. These animals are not only free from viruses and rejection-triggering proteins, but also raised in controlled, sterile environments to ensure safety at every stage. Our work combines world-class genetic science with a deeply Indian goal, expanding access to healthcare in a way that’s affordable, ethical, and built for local realities.

But science is only half the story.
The rest is Personal.

Our Team

Dr. Pravin Kini, M.D

Co-Founder

Pravin is a deep-tech multi-domain entrepreneur whose ventures sit at the intersection of science, sustainability, and scale. As the founder of numerous pioneering companies, he has spent his career building future-forward enterprises that challenge convention and drive systemic change. Whether advancing assisted reproduction, revolutionising livestock genetics, furthering quantum cybersecurity, developing clean fusion energy, or unlocking the potential of cross-species organ transplants, he approaches each venture with the precision of a scientist and the audacity of a disruptor. He thrives in ambiguity, embraces risk, and sees India not just as a market, but as a launchpad for global impact.

Dr. Pravin Kini, M.D.

Co-Founder

Aluri Srinivas Rao

Co-Founder

Professor Simon Best,
OBE, FRCS

Co-Founder

Neeladri Chowdhury

Chief Scientific Officer

Dr. Pravin Kini, M.D

Co-Founder

Pravin is a deep-tech multi-domain entrepreneur whose ventures sit at the intersection of science, sustainability, and scale. As the founder of numerous pioneering companies, he has spent his career building future-forward enterprises that challenge convention and drive systemic change. Whether advancing assisted reproduction, revolutionising livestock genetics, furthering quantum cybersecurity, developing clean fusion energy, or unlocking the potential of cross-species organ transplants, he approaches each venture with the precision of a scientist and the audacity of a disruptor. He thrives in ambiguity, embraces risk, and sees India not just as a market, but as a launchpad for global impact.

Aluri Srinivas Rao

Co-Founder

Aluri has mamy decades of experience as a business leader and investor having held prestigious positions as director of investments at ICICI Ventures and Managing Director of Private Equity at Morgan Stanley. Since then he turned his focus to deep-tech by founding revolutionary quantum cybersecurity and livestock genetics companies. Leveraging financial regulations and strategic acumen, he has built partnerships that amplify impact on global challenges, echoing his commitment to leadership and transformative change.

Professor Simon G, OBE, FRSE

Co-Founder

Simon is a World Economic Forum “Global Leader of Tomorrow” and experienced Angel, Venture Capital and Private Equity investor. Currently Chairman of MiAlgae and an Investor-Director of Roslin Technologies – the leading provider of pluripotent starter-cell lines for the production of cultured meat. Previous Chairman of ICRISAT in Hyderabad and founding CEO of Roslin BioMed which he spun out of the Roslin Institute in 1998 to commercialize the Nuclear Transfer cloning platform which enabled “Dolly the Sheep” and the University of Edinburgh’s Centre for Regenerative Medicine. Founding Investor in Tropical Animal Genetics and Jiva Sciences. Previous Vice-Chair of the US Biotechnology Industry Organization (BIO), Chair of BIO’s Bioethics Committee and the UK Biotechnology Industry Assocation (BIA).

Neeladri Chowdhury

Chief Scientific Officer

Neeladri is a biotechnology scientist with 10 years’ experience spanning regenerative medicine, agritech, and medical-device innovation. At Nuvedo Labs he directs R&D for medicinal mushroom ingredients, engineering a streamlined extraction workflows and novel product formats bringing biotechnological principles to the wellness space. During his time at C-CAMP he helped create a droplet-microfluidic, single-cell analysis platform (OptiDrop) for multiplexed analysis and sorting of biological samples. He also developed a novel biopesticide from a soil microbe, developing semi-automated high throughput screening workflows, fermentation process scale-up and performing biomolecular characterisation, the technology has now been licensed to an agritech giant for commercialisation. At Prana he hopes to leverage his decade long inter-disciplinary experience working across different areas of biotech to lead the development of Xenotransplantation in India.